Hedge Funds Private Equity and Hedge Funds

More

  • HONG KONG, Feb 4- The board of Bank of East Asia Ltd should sell the lender to deliver better returns to investors, activist shareholder hedge fund Elliott Management Corp said on Thursday, heaping pressure on one of Hong Kong's last family-controlled banks. New York- based Elliott owns 7 percent of the bank and has agitated in the past over perceived failings in...

  • Feb 3- Two thirds of hedge funds create genuine value through contrarian strategies, choosing well among cheap and beaten-down stocks, according to a new study of their holdings. The study, released in January, is ground-breaking, according to its authors, because it relies on 13 F filings, which are holdings disclosures that money managers above a certain size...

  • NEW YORK/ CHICAGO, Feb 3- The bankrupt operating unit of Caesars Entertainment Corp on Wednesday proposed mediation in its Chapter 11 case, potentially changing the course of the litigious, drawn-out bankruptcy proceedings. Angry creditors have accused Caesars of looting the operating unit before its bankruptcy to benefit private equity owners Apollo...

  • Private equity may be Wall Street’s canary Wednesday, 3 Feb 2016 | 12:00 PM ET
    Chart down

    Private equity is disappointing analysts, buying fewer companies and making less exits.

  • Activist hedge fund firm Orange Capital to shut -sources Wednesday, 3 Feb 2016 | 10:19 AM ET

    NEW YORK, Feb 3- Orange Capital, the activist hedge fund firm led by New York- based real estate investment manager Daniel Lewis, is shutting down after a year of poor performance, according to people familiar with the situation. A group of stocks in Orange's portfolio, worth about $1.3 billion as of September 30, according to a public filing, declined substantially...

  • Starboard discloses 7% stake in Marvell Wednesday, 3 Feb 2016 | 8:40 AM ET
    A Marvell Technology Group Ltd. flag flies outside the company's headquarters building in Santa Clara, California.

    Starboard Value disclosed a 7 percent stake in chipmaker Marvell Technology on Wednesday, saying it believed that the shares were "undervalued."

  • *Q4 earnings/shr 93 cents vs est 70 cents. *Shares up as much as 4 pct at $44.46. Activist investor Daniel Loeb of hedge fund Third Point has been calling for the removal of Liveris from the merged company.

  • Feb 1- Activist hedge fund Hudson Executive Capital LP wants CIT Group Inc to break up, the Wall Street Journal reported, citing people familiar with the matter. The hedge fund, which disclosed a 0.5 percent stake in CIT, thinks the best strategy for the commercial lender would be to sell off its various pieces given its recent underperformance, the Journal said.

  • Icahn, others get burned by bad Cheniere bet Monday, 1 Feb 2016 | 2:49 PM ET
    Carl Icahn at Delivering Alpha 2015 in New York.

    Big hedge funds bought more Cheniere Energy stock to end 2015. 2016 may leave them regretting it.

  • Herbalife, Ackman cleared by govt probes: WSJ Monday, 1 Feb 2016 | 2:38 PM ET
    Bill Ackman at Delivering Alpha 2015 in New York on July 15, 2015.

    Shares of Herbalife started the week more than 2 percent higher after government probes reportedly cleared the company.

  • Feb 1- Medical device maker Stryker Corp said it would buy Sage Products LLC, which makes products used in intensive care units, from private equity firm Madison Dearborn Partners for $2.78 billion. The Kalamazoo, Michigan- based device maker also raised its 2016 adjusted earnings forecast by 5 cents to $5.55 -5.75 per share. J.P. Morgan Securities LLC is the...

  • Feb 1- Medical device maker Stryker Corp said it would buy Sage Products LLC, which makes products used in intensive care units, from private equity firm Madison Dearborn Partners for $2.78 billion.

  • UBS hires ex-Brevan Howard staff for wealth arm Sunday, 31 Jan 2016 | 7:01 PM ET
    Swiss bank UBS in Midtown Manhattan

    Wealth management arm of Swiss investment bank has created a new team to meet demand from ultra-wealthy clients for shorter-term trading options.

  • Break the PBOC? Funds aim at China's yuan: Report Sunday, 31 Jan 2016 | 11:44 AM ET
    Yuan currency China

    The Wall Street Journal reports that some of the largest hedge funds on Wall Street are stacking up bets against the yuan.

  • Check out the digs JPMorgan has for millennials Saturday, 30 Jan 2016 | 5:00 PM ET
    Two young people working together at a startup or small business.

    JPMorgan Chase's plan to lure millennial talent to its tech team comes with bells, whistles -- and a new office.

  • So-called global macro funds, like the ones run by industry icons Paul Tudor Jones, Alan Howard and Ray Dalio, are expected to rank among this year's best performers, according to J.P. Morgan's Institutional Investor Survey 2016, gathering input from 322 investors controlling $910 billion in assets. The new appetite has been on display at former Brevan Howard...

  • Money managers, including hedge funds and other big speculators, raised their combined futures and options position in New York and London by 15,717 contracts to 68,053 in the week to Jan. 26, the U.S. Commodity Futures Trading Commission said. "It looked as if up to last Tuesday, you had a big influx of money-manager longs- that would explain why up until Tuesday last...

  • NEW YORK, Jan 29- Samantha Greenberg, a partner at $16.2 billion Paulson& Co., is leaving to launch her own hedge fund firm, according to people familiar with the situation. Greenberg and a spokesman for Paulson, led by billionaire John Paulson, declined to comment. She was named to the Hedge Fund Journal and Ernst& Young's 50 Leading Women in Hedge Funds for 2013.

  • *Caesars wants a decision before a March trial in New York. CHICAGO, Jan 29- The bankrupt operating unit of Caesars Entertainment Corp will soon ask a U.S. judge to shield its parent from $12 billion of lawsuits to facilitate a debt-cutting rescue deal, but approval could set a bad precedent for creditors. Hedge fund bondholders have sued Caesars in New York and...

  • Led by Chief Executive Gualtiero Pasquarelli, Doc Generici ranks as one the leading suppliers of cheap generic drugs in Italy and competes with international players such as Teva and Sandoz, part of Swiss drugmaker Novartis. The London- based private equity house wants to cash out before a new wave of patent expirations takes place in Italy in 2017, hoping to...